(Q36751350)

16 August 2017

0 references

The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials (English)

1 reference

16 August 2017

1 reference

Soliman S

1

1 reference

16 August 2017

Daya S

series ordinal

2

1 reference

16 August 2017

Collins J

series ordinal

3

1 reference

16 August 2017

Hughes EG

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

16 August 2017

published in

Fertility and Sterility

1 reference

16 August 2017

volume

61

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

1068-1076

1 reference

A method for the estimation of fecundability

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Enhancement of human implantation by exogenous chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Efficacy of progesterone support in the luteal phase following in-vitro fertilization and embryo transfer: meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

The effect of progesterone supplementation around the time of oocyte recovery in patients superovulated for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Hormonal monitoring for in-vitro fertilization and related procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

The effect of progesterone supplementation prior to the induction of ovulation in women treated for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Support of the luteal phase in in vitro fertilization programs: Results of a controlled trial with intramuscular proluton

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Immediate versus delayed progesterone supplementation in gamete intrafallopian transfer (GIFT)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Comparison of luteal-phase support with high- and low-dose progesterone therapy on pregnancy rates in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Early luteal serum progesterone concentrations are higher in pregnancy cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

The effect of dydrogesterone supplementation in an IVF programme

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

The primary treatment of luteal phase inadequacy: progesterone versus clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Unexplained infertility: evaluation of treatment with clomiphene citrate and human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

Is there a place for the crossover design in infertility trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956758-2

7 January 2021

10.1016/S0015-0282(16)56758-2

Identifiers

DOI

0 references

1 reference